Pharmacotherapy of apnoea-free sleep disorders in patients with metabolic syndrome

Aim. To evaluate the effectiveness and safety of zopiclone in apnoea-free sleep disorders among patients with metabolic syndrome (MS). Material and methods. The study included 60 patients with chronic cerebrovascular disease (CerVD) and MS (mean age 53,3±11,2 years). Zopiclone was administered in th...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: O. V. Lyubshina, A. L. Vertkin, M. Yu. Maksimova
Médium: Artigo
Jazyk:Russo
Vydáno: «SILICEA-POLIGRAF» LLC 2010-04-01
Edice:Кардиоваскулярная терапия и профилактика
Témata:
chronic cerebrovascular disease
metabolic syndrome
sleep disorders
insomnia
zopiclone
On-line přístup:https://cardiovascular.elpub.ru/jour/article/view/2042
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky